FDA Approved: CLOPIDOGREL — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved a supplemental application for clopidogrel bisulfate from Aurobindo Pharma Limited, confirming regulatory approval for this generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome
• Myocardial Infarction
• Peripheral Arterial Disease
• Stroke
• Transient Ischemic Attack

Drugs mentioned

• CLOPIDOGREL (CLOPIDOGREL)

Snippet

SUPPL AP for CLOPIDOGREL (CLOPIDOGREL BISULFATE)